| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA2261176
Max Phase: Preclinical
Molecular Formula: C15H22O4
Molecular Weight: 266.34
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCCCCOC(=O)COc1ccc(C)cc1OC
Standard InChI: InChI=1S/C15H22O4/c1-4-5-6-9-18-15(16)11-19-13-8-7-12(2)10-14(13)17-3/h7-8,10H,4-6,9,11H2,1-3H3
Standard InChI Key: UVLFAQNCFYRAAP-UHFFFAOYSA-N
Associated Targets(non-human)
Cryptococcus bacillisporus 1003 Activities
Cryptococcus neoformans var. neoformans 131 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 266.34 | Molecular Weight (Monoisotopic): 266.1518 | AlogP: 3.12 | #Rotatable Bonds: 8 |
| Polar Surface Area: 44.76 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.56 | CX LogD: 3.56 |
| Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.54 | Np Likeness Score: -0.57 |
References
| 1. Jimenez F, Cruz MdC, Zuniga C, Martinez MA, Chamorro G, Diaz F, Tamariz J. (2010) Aryloxyacetic esters structurally related to -Asarone as potential antifungal agents, 19 (1): [10.1007/s00044-009-9170-3] |
Source
Source(1):